Skip to search formSkip to main contentSkip to account menu

PA-457

Known as: PA 457, PA-457 di-NMG, PA103001 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Bevirimat Dimegluminebevirimat
MPC-4326

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Characterization of a Novel Type of HIV-1 Particle Assembly Inhibitor Using a Quantitative Luciferase-Vpr Packaging-Based Assay
The HIV-1 auxiliary protein Vpr and Vpr-fusion proteins can be copackaged with Gag precursor (Pr55Gag) into virions or membrane… 
2008
2008
The Maturation Inhibitor Bevirimat (PA-457) can be Active in Patients Carrying HIV type-1 non-B Subtypes and Recombinants
Background Bevirimat (PA-457) is the first candidate of a new family of antiretroviral drugs, the maturation inhibitors. Its… 
2008
2008
Moronic Acid and Other Triterpene Derivatives as Novel Potent Anti-HIV Agents 1
In a continuing structure-activity relationship study of potent anti-HIV agents, seven new triterpene derivatives were designed… 
2006
2006
Structural Characterization of Anti-HIV Drug Candidate PA-457 [3-O-(3′,3′-Dimethylsuccinyl)-betulinic acid] and Its Acyl Glucuronides in Rat Bile and Evaluation of in Vitro Stability in Human and…
PA-457 [3-O-(3′,3′-dimethylsuccinyl)-betulinic acid] represents a new class of anti-HIV drug candidates termed maturation… 
Review
2006
Review
2006
On the horizon: promising investigational antiretroviral agents.
Human immunodeficiency virus (HIV) infection affects close to 40 million individuals worldwide. Since 1981 when the first case… 
2005
2005
PA-457, new kind of antiretroviral: ten-day clinical trial results.
A new kind of antiretroviral, called a maturation inhibitor, worked well in reducing viral load in a ten-day trial with HIV… 
2004
2004
5th Antiviral Drug Discovery & Development Summit
The 5th Antiviral Drug Discovery and Development Summit provided an up-to-date snapshot of the ongoing developments in the area… 
2004
2004
5th Antiviral Drug Discovery and Development Summit.
The 5th Antiviral Drug Discovery and Development Summit provided an up-to-date snapshot of the ongoing developments in the area… 
2002
2002
QoS classification for mobile networks: international roaming case study
We are interested in modeling the quality of service (QoS) parameters from end-to-end when using a mobile network. We know that… 
1992
1992
Aqueous Stability and Solubility of CI-988, a Novel “Dipeptoid” Cholecystokinin-B Receptor Antagonist
The aqueous solubility and solution stability of the N-methylglucamine and sodium salts of CI-988 (CI-988 NMG and CI-988 Na) were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)